Genome-wide characterization of alternative splicing in blood cells of COVID-19 and respiratory infections of relevance

• The first global exploration of alternative splicing changes in COVID-19 and relevant respiratory diseases. • The specificities and similarities between alternative splicing events in different respiratory diseases. • Identification of regulatory network of RBP and alternative splicing in respiratory diseases. • Defining the interactions of alternative splicing and cell abundance in respiratory diseases.